AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Implementing a High-Sensitivity Troponin I Assay

  • Credit:1.0 ACCENT
  • Duration: 1 hr
  • Date:FEB.13.2019 1:00 PM - 02:00 PM

Price: $0.00

Member Price: $0.00

Rating: Member Average

Visit Siemens Healthineers for more information on the clinical tools essential to quickly and confidently triage cardiac patients to ensure health patient outcomes.


Is your lab ready to implement high-sensitivity troponin I testing? The Fourth Universal Definition of Myocardial Infarction recommends high-sensitivity troponin assays for routine clinical use. Compared to standard (guideline-acceptable) cardiac troponin assays, high-sensitivity troponin assays offer improved sensitivity and unparalleled precision at the low end of the measuring range. With the availability of high-sensitivity troponin I assays in the U.S., more laboratories now have the opportunity to implement these assays in clinical practice. Join Dr. Allan Jaffe, a highly regarded researcher and advisor on using and interpreting troponin I results, to learn about the latest recommendations and communications labs need to have with key clinical partners when they transition to high-sensitivity troponin assays.

What you will learn

  • The latest recommendations for the Fourth Universal Definition of Myocardial Infarction

  • How to discriminate myocardial infarction from myocardial injury when troponin values are elevated

  • Common questions to expect from your clinical stakeholders and how to proactively collaborate


Allan Jaffe photoAllan Jaffe, M.D.
Division of Clinical Core Laboratory Services Chair
Department of Laboratory Medicine and Pathology
Mayo Clinic
Rochester, MN


aacc sponsor logo image